dipyridamole has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bult, H; Fret, HR; Herman, AG; Jordaens, FH | 1 |
| Giessler, C; Mentz, P; Pawelski, KE | 1 |
| Flammer, J; Lüscher, TF; Meyer, P | 1 |
| Enke, B; Forssmann, WG; Ghofrani, HA; Grimminger, F; Schermuly, RT; Seeger, W; Walmrath, D; Weissmann, N | 1 |
| Ghofrani, HA; Grimminger, F; Leuchte, H; Roehl, A; Schermuly, RT; Seeger, W; Walmrath, D; Weissmann, N | 1 |
| Naik, JS; Walker, BR | 1 |
| Ghofrani, HA; Grimminger, F; Krupnik, E; Rose, F; Schermuly, RT; Schudt, C; Seeger, W; Tenor, H; Walmrath, D; Weissmann, N | 1 |
| De Wolf, D; Foubert, L; Mareels, K; Mortier, E; Reyntjens, K; Van Belleghem, Y; Van Nooten, G | 1 |
| De Somer, F; De Wolf, D; Foubert, L; Mortier, E; Reyntjens, K; Van Belleghem, Y; Van Nooten, G | 1 |
9 other study(ies) available for dipyridamole and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
Dipyridamole potentiates the anti-aggregating and vasodilator activity of nitric oxide.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Adenosine Diphosphate; Animals; Aorta, Thoracic; Dipyridamole; Drug Synergism; Epoprostenol; In Vitro Techniques; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitroglycerin; Phenylephrine; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Rabbits; Vasodilation | 1991 |
Drug induced inhibition of the cardiac effects of U 46619 as a thromboxane A2-like agonist.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blood Pressure; Cardiovascular Agents; Dipyridamole; Guinea Pigs; Heart; Heart Atria; Myocardial Contraction; Propranolol; Prostaglandin Endoperoxides, Synthetic; Trapidil; Verapamil | 1984 |
Effect of dipyridamole on vascular responses of porcine ciliary arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arginine; Ciliary Body; Colforsin; Cyclooxygenase Inhibitors; Dipyridamole; Endothelins; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Indomethacin; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Prostaglandin Endoperoxides, Synthetic; Swine; Thromboxane A2; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 1996 |
Urodilatin, a natriuretic peptide stimulating particulate guanylate cyclase, and the phosphodiesterase 5 inhibitor dipyridamole attenuate experimental pulmonary hypertension: synergism upon coapplication.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Administration, Inhalation; Animals; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Dipyridamole; Disease Models, Animal; Drug Synergism; Guanylate Cyclase; Hypertension, Pulmonary; Infusions, Intravenous; Peptide Fragments; Phosphodiesterase Inhibitors; Pulmonary Artery; Pulmonary Circulation; Rabbits | 2001 |
Combination of nonspecific PDE inhibitors with inhaled prostacyclin in experimental pulmonary hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Administration, Inhalation; Animals; Antihypertensive Agents; Cyclic AMP; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epoprostenol; Hypertension, Pulmonary; Nebulizers and Vaporizers; Pentoxifylline; Phosphodiesterase Inhibitors; Pressure; Pulmonary Gas Exchange; Rabbits; Theophylline; Vasoconstrictor Agents; Ventilation-Perfusion Ratio | 2001 |
Homogeneous segmental profile of carbon monoxide-mediated pulmonary vasodilation in rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Carbon Monoxide; Cyclic GMP; Dipyridamole; Enzyme Inhibitors; Heme Oxygenase (Decyclizing); Hypertension, Pulmonary; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Oxadiazoles; Peptides; Phosphodiesterase Inhibitors; Potassium Channel Blockers; Pulmonary Circulation; Quinoxalines; Rats; Rats, Sprague-Dawley; Tetraethylammonium; Vascular Resistance; Vasodilation | 2001 |
Coaerosolization of phosphodiesterase inhibitors markedly enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension. Maintenance of lung selectivity.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Aerosols; Animals; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hemodynamics; Hypertension, Pulmonary; Iloprost; Naphthyridines; Pentoxifylline; Phosphodiesterase Inhibitors; Rabbits; Vasodilation; Vasodilator Agents | 2001 |
Intravenous dipyridamole enhances the effects of inhaled nitric oxide and prevents rebound pulmonary hypertension in piglets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3',5'-Cyclic-GMP Phosphodiesterases; Administration, Inhalation; Animals; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Dipyridamole; Drug Synergism; Hypertension, Pulmonary; Injections, Intravenous; Nitric Oxide; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Recurrence; Substance Withdrawal Syndrome; Swine; Vascular Resistance | 2002 |
Intermittent nitric oxide combined with intravenous dipyridamole in a piglet model of acute pulmonary hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Anesthesia; Animals; Blood Pressure; Cardiac Output; Central Venous Pressure; Cyclic GMP; Dipyridamole; Hemodynamics; Hypertension, Pulmonary; Injections, Intravenous; Nitric Oxide; Pulmonary Artery; Swine; Vasoconstrictor Agents; Vasodilator Agents | 2003 |